US Patent Issued to INTRA-CELLULAR THERAPIES on Sept. 9 for "Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5pyrrolo[1,2,3-dequinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5pyrrolo[1,2,3-dequinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders" (New York, California, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,195, issued on Sept. 9, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5pyrrolo[1,2,3-dequinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5pyrrolo[1,2,3-dequinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders" was invented by Peng Li (New Milford, N.J.), Robert E Davis (San Diego) and Kimberly Vanover (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising the ...